Evidence map›Paper›PMID 38830861›Full record

Trial reportScientific reports2024

Repeated caffeine intake suppresses cerebral grey matter responses to chronic sleep restriction in an A

Yu-Shiuan Lin, Denise Lange, Diego Manuel Baur, Anna Foerges, Congying Chu, Changhong Li, Eva-Maria Elmenhorst, Bernd Neumaier, Andreas Bauer, Daniel Aeschbach and 2 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Sleep as the Foundation of Brain Health.Seminars in neurology · 2025
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yu-Shiuan LinCentre for Chronobiology, University Psychiatric Clinics Basel, Wilhelm Kleinstr. 27, 4002, Basel, Switzerland. ys.lin@unibas.ch.ORCID 0000-0002-3049-4166
Denise LangeDepartment of Sleep and Human Factors, Institute of Aerospace Medicine, German Aerospace Center, Cologne, Germany.
Diego Manuel BaurInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
Anna FoergesInstitute of Neuroscience and Medicine, INM-2, Forschungszentrum Jülich, Wilhelm-Johnen-Strasse, 52428, Jülich, North Rhine-Westphalia, Germany.
Congying ChuInstitute of Neuroscience and Medicine, INM-2, Forschungszentrum Jülich, Wilhelm-Johnen-Strasse, 52428, Jülich, North Rhine-Westphalia, Germany.
Changhong LiInstitute of Neuroscience and Medicine, INM-2, Forschungszentrum Jülich, Wilhelm-Johnen-Strasse, 52428, Jülich, North Rhine-Westphalia, Germany.
Eva-Maria ElmenhorstDepartment of Sleep and Human Factors, Institute of Aerospace Medicine, German Aerospace Center, Cologne, Germany.
Bernd NeumaierInstitute of Neuroscience and Medicine, INM-5, Forschungszentrum Jülich, Jülich, Germany.ORCID 0000-0001-5425-3116
Andreas BauerInstitute of Neuroscience and Medicine, INM-2, Forschungszentrum Jülich, Wilhelm-Johnen-Strasse, 52428, Jülich, North Rhine-Westphalia, Germany.
Daniel AeschbachDepartment of Sleep and Human Factors, Institute of Aerospace Medicine, German Aerospace Center, Cologne, Germany.
Hans-Peter LandoltInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.ORCID 0000-0003-0887-9403
David ElmenhorstInstitute of Neuroscience and Medicine, INM-2, Forschungszentrum Jülich, Wilhelm-Johnen-Strasse, 52428, Jülich, North Rhine-Westphalia, Germany. d.elmenhorst@fz-juelich.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence has shown that both sleep loss and daily caffeine intake can induce changes in grey matter (GM). Caffeine is frequently used to combat sleepiness and impaired performance caused by insufficient sleep. It is unclear (1) whether daily use of caffeine could prevent or exacerbate the GM alterations induced by 5-day sleep restriction (i.e. chronic sleep restriction, CSR), and (2) whether the potential impact on GM plasticity depends on individual differences in the availability of adenosine receptors, which are involved in mediating effects of caffeine on sleep and waking function. Thirty-six healthy adults participated in this double-blind, randomized, controlled study (age = 28.9 ± 5.2 y/; F:M = 15:21; habitual level of caffeine intake < 450 mg; 29 homozygous C/C allele carriers of rs5751876 of ADORA2A, an A

Indexed as

CaffeineGray MatterMagnetic Resonance ImagingPositron-Emission TomographyReceptor, Adenosine A1Sleep DeprivationAdultDouble-Blind MethodFemaleHumansMaleReceptor, Adenosine A2AYoung AdultADORA2A protein, humanCaffeineReceptor, Adenosine A1Receptor, Adenosine A2A

Identifiers

PMID38830861
PMCPMC11148136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.